Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs

被引：0
|
作者：
Takahara, Yasuhiro [1 ]
Nishida, Keiichiro [2 ]
Nakashima, Hirotaka [1 ]
Ochi, Nobuaki [1 ]
Uchida, Yoichiro [1 ]
Kato, Hisayoshi [1 ]
Itani, Satoru [1 ]
Nakamura, Makoto [1 ]
Iwasaki, Yuichi [1 ]
Tsujimura, Yoshitaka [1 ]
机构：
[1] Nippon Kokan Fukuyama Hosp, Dept Orthoped Surg, Fukuyama, Hiroshima 7210927, Japan
[2] Okayama Univ, Dept Orthopaed Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
来源：
ACTA MEDICA OKAYAMA | 2019年 / 73卷 / 06期
关键词：
high tibial osteotomy; rheumatoid arthritis; biologic DMARD; knee surgery; KNEE; OUTCOMES; JOINTS;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
High tibial osteotomy (HTO) procedure is generally contraindicated in rheumatoid arthritis (RA) patients because synovial inflammation may exacerbate joint damage post-surgery. The natural course of joint destruction in RA changed dramatically with new treatment strategies and the introduction of biologic disease-modifying anti-rheumatic drugs (bDMARDs). We report the cases of two RA patients who underwent HTO and whose disease activities were well controlled by bDMARDs. Despite their short follow-up periods, they showed acceptable objective and subjective clinical results. We believe that the combination of bDMARDs and HTO can be indicated for selected RA patients before total knee arthroplasty.
引用
收藏
页码：537 / 542
页数：6
相关论文
共 50 条
  • [21] Use of disease-modifying anti-rheumatic drugs and cardiovascular events in patients with rheumatoid arthritis
    Kaminski, Matthew
    Shishehbor, Mehdi H.
    Gutierrez, Antonio
    Amini, Mohammad R.
    Coats, Walter
    Moghbelli, Meisam
    Askari, Arman T.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A370 - A370
  • [22] Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
    Giachi, Andrea
    Cugno, Massimo
    Gualtierotti, Roberta
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [23] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis
    Roy Fleischmann
    [J]. Clinical Rheumatology, 2021, 40 : 4369 - 4372
  • [24] PREDICTIVE FACTORS FOR SUCCESSFUL BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS DOSE TAPERING IN RHEUMATOID ARTHRITIS
    Loh, Min Yi
    Jones, Claire J.
    Peall, Adrian
    Trickey, Jeanette
    [J]. RHEUMATOLOGY, 2023, 62
  • [25] Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis
    Fleischmann, Roy
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (11) : 4369 - 4372
  • [26] IMPACT OF BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN LIPID PROFILE OF PSORIATIC ARTHRITIS PATIENTS
    Guajardo-Aldaco, Andrea L.
    Galarza-Delgado, Dionicio A.
    Azpiri-Lopez, Jose R.
    Colunga-Pedraza, Iris J.
    Cardenas-de la Garza, Jesus A.
    Arvizu-Rivera, Rosa I.
    Elizondo-Benitez, Maria F.
    Gonzalez-Gonzalez, Valeria
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [27] Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada
    Roussy, Jean-Pascal
    Bessette, Louis
    Bernatsky, Sasha
    Rahme, Elham
    Legare, Jean
    Lachaine, Jean
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S855 - S855
  • [28] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS IN QUEBEC, CANADA
    Roussy, J. P.
    Bessette, L.
    Bernatsky, S.
    Rahme, E.
    Legare, J.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
  • [29] Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients
    Convertino, Irma
    Cazzato, Massimiliano
    Tillati, Silvia
    Giometto, Sabrina
    Gini, Rosa
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Bonaso, Marco
    Bartolini, Claudia C.
    Paoletti, Olga
    Lorenzoni, Valentina
    Filippi, Matteo
    Turchetti, Giuseppe
    Cristofano, Michele
    Blandizzi, Corrado
    Mosca, Marta
    Lucenteforte, Ersilia
    Tuccori, Marco
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 488 - 489
  • [30] Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
    Das, Priyam
    Weisenfeld, Dana
    Dahal, Kumar
    De, Debsurya
    Feathers, Vivi
    Coblyn, Jonathan S.
    Weinblatt, Michael E.
    Shadick, Nancy A.
    Cai, Tianxi
    Liao, Katherine P.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
12345